The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

I have been diagnosed with diabetic retinopathy. The doctor recommends intravitreal injections over a few months. It's a ...

( MENAFN - Mid-East Info) The Retina clinic London will showcase cutting-edge innovations in the diagnosis, monitoring, and ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Greg Ellwood-Hughes explores how AI is supporting ophthalmology services and the issues to be addressed in the coming years ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Could artificial intelligence replace a visit to your doctor? KYW medical editor Dr. Brian McDonough looks at research from ...

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has ...